Log in
Enquire now
T-Curx

T-Curx

Developer of T-cell-based personalized immunotherapy for cancer treatment

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
CEO
‌
Ulf Grawunder
Company Operating Status
Active
COO
‌
Marion Jung
Country
Germany
Germany
Email Address
info@t-curx.com
Founded Date
2017
Founder
‌
Ulf Grawunder
‌
Michael Hudecek
Headquarters
Bavaria
Bavaria
Industry
Health technology
Health technology
Biotechnology
Biotechnology
Stem cell
Stem cell
Immunotherapy
Immunotherapy
Regenerative medicine
Regenerative medicine
Cell therapy
Cell therapy
Biomedical engineering
Biomedical engineering
Investors
BioMedPartners
BioMedPartners
Highlight Capital
Highlight Capital
‌
i&i Biotech Fund
Bayern Kapital
Bayern Kapital
Latest Funding Round Date
December 17, 2025
Latest Funding Round Amount (USD)
20,000,000
Latest Funding Type
Series A
Series A
LinkedIn URL
@company/t-curx
Location
Germany
Germany
Number of Employees (Ranges)
1 – 10
Total Funding Amount (USD)
20,000,000
Official Website
t-curx.com

Find more companies like T-Curx

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.